Apogee Therapeutics, Inc. (APGE) Insider Trading

Over the last 3 months, APGE insiders made 0 open-market buys and 20 sales, a net sale of -$6.4M (SEC Form 4). Over the last 6 months, 209 institutions increased and 94 reduced their position (13F).

Insider Activity

Sentiment
0/100
Buys (3m)
0
Sells (3m)
20
Net (3m)
-$6.4M
Insider trades by month Buys Sells
Dec
Jan
Feb
Mar
Apr
May
Context3-month price +28.2%Institutions accumulating (13F)
DateInsiderTypeSharesPrice
May 15, 2026HENDERSON MICHAEL THOMASdirector, officer: Chief Executive OfficerSell1,341$82.58
May 15, 2026HENDERSON MICHAEL THOMASdirector, officer: Chief Executive OfficerSell18,659$82.05
May 8, 2026Dambkowski Carlofficer: Chief Medical OfficerSell3,700$83.92
May 8, 2026Dambkowski Carlofficer: Chief Medical OfficerSell1,800$84.60
May 8, 2026Dambkowski Carlofficer: Chief Medical OfficerOption4,125$22.86
May 4, 2026Henderson Janeofficer: Chief Financial OfficerSell811$81.02
May 4, 2026Henderson Janeofficer: Chief Financial OfficerSell900$82.60
May 4, 2026Henderson Janeofficer: Chief Financial OfficerSell289$83.16
Apr 20, 2026HENDERSON MICHAEL THOMASdirector, officer: Chief Executive OfficerOption3,000$22.86
Apr 17, 2026Henderson Janeofficer: Chief Financial OfficerSell2,000$90.00
Apr 10, 2026HENDERSON MICHAEL THOMASdirector, officer: Chief Executive OfficerSell17,800$82.48
Apr 10, 2026HENDERSON MICHAEL THOMASdirector, officer: Chief Executive OfficerSell200$85.00
Apr 10, 2026HENDERSON MICHAEL THOMASdirector, officer: Chief Executive OfficerSell2,000$83.26
Apr 3, 2026Henderson Janeofficer: Chief Financial OfficerSell1,100$85.46
Apr 3, 2026Henderson Janeofficer: Chief Financial OfficerSell900$84.46
Apr 3, 2026Dambkowski Carlofficer: Chief Medical OfficerSell100$85.89
Apr 3, 2026Dambkowski Carlofficer: Chief Medical OfficerSell2,702$85.33
Apr 3, 2026Dambkowski Carlofficer: Chief Medical OfficerSell2,698$84.31
Apr 3, 2026Dambkowski Carlofficer: Chief Medical OfficerOption4,125$22.86
Mar 27, 2026Henderson Janeofficer: Chief Financial OfficerSell2,000$85.00
Mar 13, 2026HENDERSON MICHAEL THOMASdirector, officer: Chief Executive OfficerSell3,418$75.86
Mar 13, 2026HENDERSON MICHAEL THOMASdirector, officer: Chief Executive OfficerSell8,363$74.29
Mar 13, 2026HENDERSON MICHAEL THOMASdirector, officer: Chief Executive OfficerSell8,219$74.83
Mar 6, 2026Dambkowski Carlofficer: Chief Medical OfficerOption4,125$22.86
Mar 6, 2026Dambkowski Carlofficer: Chief Medical OfficerSell200$73.26
Mar 6, 2026Dambkowski Carlofficer: Chief Medical OfficerSell2,075$71.98
Mar 6, 2026Dambkowski Carlofficer: Chief Medical OfficerSell3,225$70.33
Mar 4, 2026Henderson Janeofficer: Chief Financial OfficerSell300$68.27
Mar 4, 2026Henderson Janeofficer: Chief Financial OfficerSell994$70.45
Mar 4, 2026Henderson Janeofficer: Chief Financial OfficerSell406$71.66

Source: APGE SEC Form 4 filings, latest May 15, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their APGE positions over the last 6 months (SEC Form 13F).

Increased
209
New positions
99
Reduced
94
Sold out
47
Largest moves
InstitutionActionSharesFiled
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.Increased10.3MMay 15, 2026
FMR LLCIncreased9.3MMay 15, 2026
VR ADVISER, LLCUnchanged8.5MMay 15, 2026
VR ADVISER, LLCUnchanged8.5MFeb 17, 2026
FMR LLCIncreased8.2MFeb 17, 2026
WELLINGTON MANAGEMENT GROUP LLPIncreased4.7MFeb 17, 2026
WELLINGTON MANAGEMENT GROUP LLPReduced4.4MMay 15, 2026
BLACKROCK, INC.Increased4.1MMay 13, 2026
BLACKROCK, INC.Increased3.8MFeb 12, 2026
PERCEPTIVE ADVISORS LLCIncreased3.1MMay 29, 2026
VANGUARD GROUP INCIncreased2.9MJan 29, 2026
RTW INVESTMENTS, LPIncreased2.8MMay 15, 2026
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.Increased2.7MFeb 19, 2026
RTW INVESTMENTS, LPUnchanged2.7MFeb 17, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position2.5MMay 15, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.

← Back to APGE overview (price, financials, earnings)